A study to investigate the pharmacokinetics of remibrutinib in CSF in healthy participants.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506760-13-00

Acronym

CLOU064C12101

Enrollment

Registered

2023-11-07

Start date

2023-12-11

Completion date

2024-03-17

Last updated

2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026